AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 191 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $81,000 | +50.0% | 1,500 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $54,000 | -25.0% | 1,500 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $72,000 | +46.9% | 1,500 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $49,000 | -34.7% | 1,500 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $75,000 | -26.5% | 1,500 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $102,000 | +45.7% | 1,500 | -0.9% | 0.00% | 0.0% |
Q4 2018 | $70,000 | -40.2% | 1,513 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $117,000 | -7.9% | 1,513 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $127,000 | +3.3% | 1,513 | +0.9% | 0.00% | 0.0% |
Q1 2018 | $123,000 | -23.1% | 1,500 | -46.4% | 0.00% | -50.0% |
Q4 2017 | $160,000 | -14.4% | 2,800 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $187,000 | +29.9% | 2,800 | 0.0% | 0.00% | +100.0% |
Q2 2017 | $144,000 | +14300.0% | 2,800 | +69900.0% | 0.00% | – |
Q4 2015 | $1,000 | – | 4 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |